Achilles Therapeutics plc - SPONSORED ADS (ACHL)

Historical Portfolio Holders from Q1 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q2 2024
22.2M
Holdings value Q2 2024
$18.1M
Value change Q2 2024
-$1.75M
Grand Portfolio weight change Q2 2024
0%
Number of holders
26
Number of buys Q2 2024
8
Number of sells Q2 2024
-14
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 22.2M $18.1M -$1.75M $0.82 26
2024 Q1 23.5M $29.4M +$2.67M $1.25 31
2023 Q4 21.8M $19.4M -$363K $0.89 19
2023 Q3 19.7M $17.9M -$91.1K $0.91 16
2023 Q2 19.8M $18.7M -$523K $0.95 16
2023 Q1 20.2M $19.4M -$1.27M $0.96 16
2022 Q4 21.7M $19.5M -$8M $0.90 21
2022 Q3 27.3M $61.6M +$234K $2.26 25
2022 Q2 27.1M $68.4M +$1.42M $2.52 23
2022 Q1 15.5M $45.5M -$4.27M $2.94 21
2021 Q4 27.4M $137M -$12.9M $5.01 28
2021 Q3 17.6M $137M -$11.4M $7.79 19
2021 Q2 18.8M $184M +$18.2M $9.79 29
2021 Q1 16.8M $278M +$278M $16.55 29